(3R,4R)-3,4-Dihydroxydihydrofuran-2(3H)-one

Catalog No.: 
ACXEGP693
CAS No.: 
15667-21-7
Molecular Formula: 
C4H6O4
Molecular Weight: 
118.09
(3R,4R)-3,4-Dihydroxydihydrofuran-2(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$63.00In stockInquiry
100g95%$222.00In stockInquiry
500g95%$889.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,4R)-3,4-Dihydroxydihydrofuran-2(3H)-one
IUPAC Name(3R,4R)-3,4-dihydroxydihydrofuran-2(3H)-one
MDL No.MFCD00077763
Molecular FormulaC4H6O4
Molecular Weight118.09
SMILESO=C1OC[C@@H](O)[C@H]1O
InChI KeySGMJBNSHAZVGMC-PWNYCUMCSA-N
Synonym3,4-Dihydroxyoxolan-2-onato(3-) | MFCD00077763 | s11960 | Sedotussin (TN) | Q27159785 | SCHEMBL818248 | Carbamazepine10,11-Epoxide | Rel-(3R,4R)-3,4-dihydroxydihydrofuran-2(3H)-one | Erythronic acid g-lactone | d-erythrono-1,4-lactone | erythrono-1,4-lact
CAS No.15667-21-7
PubChem CID5325915

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXEGP693 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXEGP693 route product structure diagram
    ACXEGP69315667-21-7In Stock
Inquiry

2. ACXEGP693 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXEGP693 route product structure diagram
    ACXEGP69315667-21-7In Stock
Inquiry

3. ACXEGP693 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXEGP693 route product structure diagram
    ACXEGP69315667-21-7In Stock
Inquiry

Comments (0)